Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 525

    Jharkhand govt to launch medical insurance for BPL families

    Jharkhand govt to launch medical insurance for BPL families

    savita thakur thakur12 Jun 2016 4:14 PM IST
    Ranchi : Jharkhand Chief Minister Raghubar Das said a medical insurance of Rs two lakh would be launched for Below Poverty Line (BPL) people of the...
    US Panel Backs Approval For Merck Infectious Diarrhea Drug

    US Panel Backs Approval For Merck Infectious Diarrhea Drug

    savita thakur thakur12 Jun 2016 4:14 PM IST
    Merck & Co's experimental drug to treat the most common cause of hospital associated infectious diarrhea warrants approval, an advisory panel to...
    Dr Reddy

    Dr Reddy's to buy eight ANDAs in US for $350 million

    savita thakur thakur12 Jun 2016 4:13 PM IST
    New Delhi : Dr Reddy's Laboratories has inked a pact with Teva Pharmaceutical and an affiliate of Allergan Plc to buy a portfolio of eight abbreviated...
    Amgen says migraine prevention drug meets main goal of study

    Amgen says migraine prevention drug meets main goal of study

    savita thakur thakur11 Jun 2016 4:32 PM IST
    An experimental drug for prevention of chronic migraine headaches from Amgen Inc met the main goal of a midstage study by reducing the number of...
    EU wants more transparency on AbbVies Humira, worlds top drug

    EU wants more transparency on AbbVie's Humira, world's top drug

    savita thakur thakur11 Jun 2016 4:30 PM IST
    London : Details of clinical trials involving AbbVie's rheumatoid arthritis drug Humira, the world's top-selling prescription medicine, are still...
    Too many drugmakers chasing same cancer strategy :USFDA

    Too many drugmakers chasing same cancer strategy :USFDA

    savita thakur thakur11 Jun 2016 4:30 PM IST
    Chicago : A new type of cancer drug that takes the brakes off the body's immune system has given drugmakers some remarkable wins against the deadly...
    Granules acquires rights for 4 products from US pharma Windlas

    Granules acquires rights for 4 products from US pharma Windlas

    savita thakur thakur10 Jun 2016 4:20 PM IST
    New Delhi : Pharma firm Granules India said its subsidiary has entered into a product in-licensing pact with US pharma Windlas, LLC to market and...
    BRIEF-Sanofi files investor presentation with SEC on proposed acquisition of Medivation

    BRIEF-Sanofi files investor presentation with SEC on proposed acquisition of Medivation

    savita thakur thakur10 Jun 2016 4:17 PM IST
    Sanofi says filed investor presentation on proposed acquisition of Medivation with the U.S. Securities and Exchange Commission* Sanofi says its...
    Colombia to set new price for Novartis cancer drug

    Colombia to set new price for Novartis cancer drug

    savita thakur thakur10 Jun 2016 4:17 PM IST
    Bogota : Colombia will set a new price for the Novartis cancer drug imatinib in a bid to cut healthcare costs after price negotiations with the Swiss...
    Zydus gets FDA nod for phase II clinical trial of Saroglitazar

    Zydus gets FDA nod for phase II clinical trial of Saroglitazar

    savita thakur thakur9 Jun 2016 11:48 AM IST
    NEW DELHI: Drug firm Zydus Cadila said it has received approval from the US health regulator to initiate a phase II clinical trial of Saroglitazar in...
    Continue to Remain Opportunistic For Acquisitions: Sun Pharma

    Continue to Remain Opportunistic For Acquisitions: Sun Pharma

    savita thakur thakur9 Jun 2016 11:47 AM IST
    New Delhi : Keen on inorganic expansion, Sun Pharma has said it is looking for targets that are "well managed" unlike the acquisition of Ranbaxy which...
    Mylan, Biocon confirm efficacy of trastuzumab biosimilar

    Mylan, Biocon confirm efficacy of trastuzumab biosimilar

    savita thakur thakur8 Jun 2016 2:27 PM IST
    As one of the first companies in the industry to successfully complete a confirmatory efficacy and safety study comparing a proposed biosimilar to a...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Google bets on European biotech drugs, backs new fund

    Google bets on European biotech drugs, backs new fund

    FDC Ban: Avoid These Combinations of Paracetamol

    FDC Ban: Avoid These Combinations of Paracetamol

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok